ATHE (Alterity Therapeutics Limited American Depositary Shares) Stock Analysis - Financials

Alterity Therapeutics Limited American Depositary Shares (ATHE) is a publicly traded Healthcare sector company. As of May 19, 2026, ATHE trades at $4.13 with a market cap of $73.05M and a P/E ratio of 0.00. ATHE moved +0.00% today. Year to date, ATHE is +37.18%; over the trailing twelve months it is +5.73%. Its 52-week range spans $1.00 to $7.00. Analyst consensus is buy with an average price target of $12.00. Rallies surfaces ATHE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are ATHE's key financials?

ATHE financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ATHE recently traded at $4.13. Market cap is $73.05M. P/E ratio is 0.00. Revenue is $0.

ATHE Key Metrics

Key financial metrics for ATHE
MetricValue
Price$4.13
Market Cap$73.05M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$7.00
52-Week Low$1.00
Volume2.61K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest ATHE News

ATHE Analyst Consensus

1 analysts cover ATHE: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.00.

Common questions about ATHE

What are ATHE's key financials?
ATHE financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ATHE recently traded at $4.13. Market cap is $73.05M. P/E ratio is 0.00. Revenue is $0.
Is ATHE research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ATHE. It does not provide personalized investment advice.
ATHE

ATHE